Biotech & Life Sciences Global Venture Congress 2006

Throughout the conference, 30+ actively investing top-tier Biotech & Life Science Venture Capitalists will address various issues during 7 panel discussions.

Exhibitor & Presentation Opportunities: There are limited opportunities available to companies seeking funding to exhibit or present. Applications will be considered on a first-come, first-served basis. See website for detail.

Stewart J. Hen
Managing Director
Warburg Pincus

Markus Goebel, Ph.D., M.D.
Managing Director
Novartis Venture Fund

Caley M. Castelein, M.D.
Managing Partner
Thomas Weisel Healthcare Venture Partners

Philip L. Smith, Ph.D.
General Partner
SR One

Jim Sherblom
Managing General Partner
Seaflower Ventures

J. Gordon Foulkes, Ph.D.
Venture Partner
RiverVest Venture Partners

Arthur Klausner
Partner
Pappas Ventures
Gyan Parida, Ph.D.
President/CEO
SAEC, SAEC Ventures
Jonathan T. Silverstein
General Partner
OrbiMed Advisors

Dan Burstein
Managing Partner
Millennium Technology Ventures

Andrew D. Firlik, M.D.
General Partner
Foundation Medical Partners

Timothy F. Howe
Partner
CHL Medical Partners

Rodney D. Altman, M.D.
Senior Partner
CMEA Ventures

David F. Hendren
Managing Director/Founder
Catalyst Health & Technology Partners

John Wilkerson, Ph.D.
Managing Director/Co-founder
Galen Partners

Paul M. Kelley
Chairman/Founder
Zero Stage Capital

Alfred Scheidegger, Ph.D.
Founding Partner & CEO
Nextech Venture Ltd.(Zurich)

Scott Minick
Managing Director
ARCH Venture Partners

Jerry Benjamin
General Partner
Advent Venture Partners

…and more